|
1
|
Jess T, Rungoe C and Peyrin-Biroulet L:
Risk of colorectal cancer in patients with ulcerative colitis: A
meta-analysis of population-based cohort studies. Clin
Gastroenterol Hepatol. 10:639–645. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jess T, LoftusEV Jr, Velayos FS, Harmsen
WS, Zinsmeister AR, Smyrk TC, Tremaine WJ, Melton LJ III, Munkholm
P and Sandborn WJ: Incidence and prognosis of colorectal dysplasia
in inflammatory bowel disease: A population-based study from
Olmsted County, Minnesota. Inflamm Bowel Dis. 12:669–676. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Brentnall TA, Haggitt RC, Rabinovitch PS,
Kimmey MB, Bronner MP, Levine DS, Kowdley KV, Stevens AC, Crispin
DA, Emond M and Rubin CE: Risk and natural histoy of colonic
neoplasia in patients with primary sclerosing cholangitis and
ulcerative colitis. Gastroenterology. 110:331–338. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nuako KW, Ahlquist DA, Mahoney DW, Schaid
DJ, Siems DM and Lindor NM: Familial predisposition for colorectal
cancer in chronic ulcerative colitis: A case-control study.
Gastroenterology. 115:1079–1083. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Devroede GJ, Taylor WF, Sauer WG, Jackman
RJ and Stickler GB: Cancer risk and life expectancy of children
with ulcerative colitis. N Engl J Med. 285:17–21. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
D'Incà R, Cardin R, Benazzato L, Angriman
I, Martines D and Sturniolo GC: Oxidative DNA damage in the mucosa
of ulcerative colitis increases with disease duration and
dysplasia. Inflamm Bowel Dis. 10:23–27. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kojima M, Morisaki T, Tsukahara Y,
Uchiyama A, Matsunari Y, Mibu R and Tanaka M: Nitric oxide synthase
expression and nitric oxide production in human colon carcinoma
tissue. J Surg Oncol. 70:222–229. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Choudhari SK, Chaudhary M, Bagde S,
Gadbail AR and Joshi V: Nitric oxide and cancer: A review. World J
Surg Oncol. 11:1182013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vannini F, Kashfi K and Nath N: The dual
role of iNOS in cancer. Redox Biol. 6:334–343. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nakabeppu Y, Tsuchimoto D, Ichinoe A, Ohno
M, Ide Y, Hirano S, Yoshimura D, Tominaga Y, Furuichi M and Sakumi
K: Biological significance of the defense mechanisms against
oxidative damage in nucleic acids caused by reactive oxygen
species: From mitochondria to nuclei. Ann N Y Acad Sci.
1011:101–111. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shibutani S, Takeshita M and Grollman AP:
Insertion of specific bases during DNA synthesis past the
oxidation-damaged base 8-oxodG. Nature. 349:431–434. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Vakakanidis A, Vlachogianni T and Fiotakis
C: 8-hydroxy-2′-deoxyguanosine (8-OHdG): A critical biomarker of
oxidative stress and carcinogenesis. J Environ Sci Health C Environ
Carcinog Ecotoxicol Rev. 27:120–139. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kondo S, Toyokuni S, Tanaka T, Hiai H,
Onodera H, Kasai H and Imamura M: Overexpression of the hOGG1 gene
and high 8-hydroxy-2′-deoxyguanosine (8-OHdG) lyase activity in
human colorectal carcinoma: Regulation mechanism of the 8-OHdG
level in DNA. Clin Cancer Res. 6:1394–1400. 2000.PubMed/NCBI
|
|
14
|
Sekiguchi M and Tsuzuki T: Oxidative
nucleotide damage: Consequences and prevention. Oncogene.
21:8895–8904. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
García-Quispes WA, Pérez-Machado G, Akdi
A, Pastor S, Galofré P, Biarnés F, Castell J, Velázquez A and
Marcos R: Association studies of OGG1, XRCC1, XRCC2 and XRCC3
polymorphisms with differentiated thyroid cancer. Mutat Res.
709–710:67–72. 2011. View Article : Google Scholar
|
|
16
|
Kubo N, Morita M, Nakashima Y, Kitao H,
Egashira A, Saeki H, Oki E, Kakeji Y, Oda Y and Maehara Y:
Oxidative DNA damage in human esophageal cancer:
Clinicopathological analysis of 8-hydroxydeoxyguanosine and its
repair enzyme. Dis Esophagus. 27:285–293. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Karihtala P, Kauppila S, Puistola U and
Jukkola-Vuorinen A: Absence of the DNA repair enzyme human
8-oxoguanine glycosylase is associated with an aggressive breast
cancer phenotype. Br J Cancer. 106:344–347. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gushima M, Hirahashi M, Matsumoto T,
Fujita K, Fujisawa R, Mizumoto K, Nakabeppu Y, Iida M, Yao T and
Tsuneyoshi M: Altered expression of MUTYH and an increase in
8-hydroxydeoxyguanosine are early events in ulcerative
colitis-associated carcinogenesis. J Pathol. 219:77–86. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Grasso F, Di Meo S, de Luca G, Pasquini L,
Rossi S, Boirivant M, Biffoni M, Bignami M and Di Carlo E: The
MUTYH base excision repair gene protects against
inflammation-associated colorectal carcinogenesis. Oncotarget.
6:19671–19684. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Scarpa M, Castagliuolo I, Castoro C, Pozza
A, Scarpa M, Kotsafti A and Angriman I: Inflammatory colonic
carcinogenesis: A review on pathogenesis and immunosurveillance
mechanisms in ulcerative colitis. World J Gastroenterol.
20:6774–6785. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yin J, Harpaz N, Tong Y, Huang Y, Laurin
J, Greenwald BD, Hontanosas M, Newkirk C and Meltzer SJ: p53 point
mutations in dysplastic and cancerous ulcerative colitis lesions.
Gastroenterology. 104:1633–1639. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Borger DR, Tanabe KK, Fan KC, Lopez HU,
Fantin VR, Straley KS, Schenkein DP, Hezel AF, Ancukiewicz M
Liebman HM, et al: Frequent mutation of isocitrate dehydrogenase
(IDH)1 and IDH2 in cholangiocarcinoma identified through
broad-based tumor genotyping. Oncologist. 17:72–79. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hartman DJ, Binion D, Regueiro M, Schraut
W, Bahary N, Sun W, Nikiforova M and Pai RK: Isocitrate
dehydrogenase-1 is mutated in inflammatory bowel disease-associated
intestinal adenocarcinoma with low-grade tubuloglandular histology
but not in sporadic intestinal adenocarcinoma. Am J Surg Pathol.
38:1147–1156. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Riddell RH, Goldman H, Ransohoff DF,
Appelman HD, Fenoglio CM, Haggitt RC, Ahren C, Correa P, Hamilton
SR, Morson BC, et al: Dysplasia in inflammatory bowel disease:
Standardized classification with provisional clinical applications.
Human Pathol. 11:931–968. 1983. View Article : Google Scholar
|
|
25
|
Brennan PA, Palacios-Callender M, Zaki GA,
Spedding AV and Langdon JD: Type II nitric oxide synthase (NOS2)
expression correlates with lymph node status in oral squamous cell
carcinoma. J Oral Pathol Med. 30:129–134. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Maehara Y, Tomoda M, Hasuda S, Kabashima
A, Tokunaga E, Kakeji Y and Sugimachi K: Prognostic value of p53
protein expression for patients with gastric cancer- a multivariate
analysis. Br J Cancer. 79:1255–1261. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Feng CW, Wang LD, Jiao LH, Liu B, Zheng S
and Xie XJ: Expression of p53, inducible nitric oxide synthase and
vascular endothelial growth factor in gastric precancerous and
cancerous lesions: Correlation with clinical features. BMC Cancer.
2:82002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Oda Y, Sakamoto A, Satio T, Kawauchi S,
Iwamoto Y and Tsuneyoshi M: Molecular abnormalities of p53, MDM2
and H-ras in synovial sarcoma. Mod Pathol. 13:994–1004. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fujita K, Yamamoto H, Matsumoto T,
Hirahashi M, Gushima M, Kishimoto J, Nishiyama K, Taguchi T, Yao T
and Oda Y: Sessile serrated adenoma with early neoplastic
progression: A clinicopathologic and molecular study. Am J Surg
Pathol. 35:295–304. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kajitani K, Yamaguchi H, Dan Y, Furuichi
M, Kang D and Nakabeppu Y: MTH1, an oxidized purine nucleoside
triphosphatase, suppresses the accumulation of oxidative damage of
nucleic acids in the hippocampal microglia during kainate-induced
excitotoxicity. J Neurosci. 26:1688–1698. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liao J, Seril DN, Lu GG, Zhang M, Toyokuni
S, Yang AL and Yang GY: Increased susceptibility of chronic
ulcerative colitis-induced carcinoma development in DNA repair
enzyme Ogg1 deficient mice. Mol Carcinog. 47:638–646. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Nakabeppu Y: Cellular levels of
8-oxoguanine in either DNA or the nucleotide pool play pivotal
roles in carcinogenesis and survival of cancer cells. Int J Mol
Sci. 15:12543–12557. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tsuzuki T, Egashira A, Igarashi H, Iwakuma
T, Nakatsuru Y, Tominaga Y, Kawate H, Nakao K, Nakamura K, Ide F,
et al: Spontaneous tumorigenesis in mice defective in the MTH1 gene
encoding 8-oxo-dGTPase. Proc Natl Acad Sci USA. 98:11456–11461.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Song WJ, Jiang P, Cai JP and Zheng ZQ:
Expression of cytoplasmic 8-oxo-Gsn and MTH1 correlates with
pathological grading in human gastric cancer. Asian Pac J Cancer
Prev. 16:6335–6338. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gad H, Koolmeister T, Jemth AS, Eshtad S,
Jacques SA, Ström CE, Svensson LM, Schultz N, Lundbäck T,
Einarsdottir BO, et al: MTH1 inhibition eradicates cancer by
preventing sanitation of the dNTP pool. Nature. 508:215–221. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Huber KV, Salah E, Radic B, Gridling M,
Elkins JM, Stukalov A, Jemth AS, Göktürk C, Sanjiv K, Strömberg K,
et al: Stereospecific targeting of MTH1 by (S)-crizotinib as an
anticancer strategy. Nature. 508:222–227. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chaubert P, Benhattar J, Saraga E and
Costa J: K-ras mutations and p53 alterations in neoplastic and
nonneoplastic lesions associated with longstanding ulcerative
colitis. Am J Pathol. 144:767–775. 1994.PubMed/NCBI
|
|
38
|
Oka S, Leon J, Tsuchimoto D, Sakumi K and
Nakabeppu Y: MUTYH, an adenine DNA glycosylase, mediates p53 tumor
suppression via PARP-dependent cell death. Oncogenesis. 4:e1422015.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chatterjee A..Mambo E, Osada M, Upadhyay S
and Sidransky D: The effect of p53-RNAi and p53 knockout on human
8-oxoguanine DNA glycosylase (hOgg1) activity. FASEB J. 20:112–114.
2006. View Article : Google Scholar : PubMed/NCBI
|
